The White House budget set for release Monday will include almost $17 billion to fight opioid addiction; a profile of FDA chief Scott Gottlieb, MD, describes him as someone who's become adept at balancing competing interests; the Trump administration is set to appoint a new drug czar with no public health experience.
The White House’s fiscal 2019 budget set to be released Monday will include nearly $17 billion for the opioid epidemic, The Hill reported. HHS will received the bulk of the money to expand prevention, treatment, recovery and mental health services—$3 billion for 2018 and $10 billion for 2019.
Scott Gottlieb, MD, is approaching his FDA job as chief of the agency in a more conventional way than other administration appointees, The New York Times reported this weekend. He is keeping both the president and industry supporters satisfied while also quieting some skeptics, and is trying to balance protecting public health while also offering rewards to industry.
The While House deputy chief of staff, an attorney with no public health experience, is slated to become the next head of the Office of National Drug Control Policy, STAT reported. Jim Carroll would serve as the administration’s next drug czar. In related news, health advocates are waiting to see if the office is still slated to see its budget cut 95% in the administration’s upcoming budget.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Homelessness Compounds Hospital Stay Challenges: Study Reveals Prolonged Discharge Struggles
March 28th 2024In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a homeless population, and whether age and/or injury severity had an influence on that relationship—with implications for improving the discharge process for these patients.
Read More
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More